Global Chimeric Antigen Receptor Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 58481
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 138
  • list Pharmaceuticals and Healthcare
Buy @ $3480


Scope of the Report:
The global Chimeric Antigen Receptor Cell Therapy market is valued at xx million USD in 2020 and is expected to reach xx million USD by the end of 2026, growing at a CAGR of xx% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chimeric Antigen Receptor Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
This report studies the Chimeric Antigen Receptor Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chimeric Antigen Receptor Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Monotherapy
Combination Therapy

Market Segment by Applications, can be divided into
Acute Leukemia
Non-hodgkin's Lymphoma
Multiple Myeloma
Transplant Rejection
Other
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Chimeric Antigen Receptor Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor Cell Therapy
1.2 Classification of Chimeric Antigen Receptor Cell Therapy by Types
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Comparison by Types (2020-2026)
1.2.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Types in 2018
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Chimeric Antigen Receptor Cell Therapy Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size and Market Share Comparison by Applications (2015-2026)
1.3.2 Acute Leukemia
1.3.3 Non-hodgkin's Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Other
1.4 Global Chimeric Antigen Receptor Cell Therapy Market by Regions
1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (Million USD) Comparison by Regions (2015-2026)
1.4.1 North America (USA, Canada and Mexico) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2026)
1.4.4 South America (Brazil, Argentina, Colombia) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2026)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chimeric Antigen Receptor Cell Therapy Status and Prospect (2015-2026)
1.5 Global Market Size of Chimeric Antigen Receptor Cell Therapy (2015-2026)
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Business Overview
2.1.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Autolus Therapeutics Plc
2.2.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
2.3.1 Business Overview
2.3.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bellicum Pharmaceuticals Inc
2.4.1 Business Overview
2.4.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Co
2.5.1 Business Overview
2.5.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 bluebird bio Inc
2.6.1 Business Overview
2.6.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 CARsgen Therapeutics Ltd
2.7.1 Business Overview
2.7.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celgene Corp
2.8.1 Business Overview
2.8.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cell Medica Ltd
2.9.1 Business Overview
2.9.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cellular Biomedicine Group Inc
2.10.1 Business Overview
2.10.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Celularity Inc
2.11.1 Business Overview
2.11.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Celyad SA
2.12.1 Business Overview
2.12.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Business Overview
2.13.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Fosun Pharmaceutical AG
2.14.1 Business Overview
2.14.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Gilead Sciences Inc
2.15.1 Business Overview
2.15.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
2.16.1 Business Overview
2.16.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hangzhou Converd Co Ltd
2.17.1 Business Overview
2.17.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Hebei Senlang Biotechnology Inc Ltd
2.18.1 Business Overview
2.18.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.19 HRAIN Biotechnology Co Ltd
2.19.1 Business Overview
2.19.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.20 Juno Therapeutics Inc
2.20.1 Business Overview
2.20.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.21 Kite Pharma Inc
2.21.1 Business Overview
2.2.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.22 Nanjing Legend Biotech Co Ltd
2.22.1 Business Overview
2.22.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.23 NantKwest Inc
2.23.1 Business Overview
2.23.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.24 Nkarta Inc
2.24.1 Business Overview
2.24.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.25 Novartis AG
2.25.1 Business Overview
2.25.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.26 Ono Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
2.27.1 Business Overview
2.27.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.28 Sorrento Therapeutics Inc
2.28.1 Business Overview
2.28.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.29 Takara Bio Inc
2.29.1 Business Overview
2.29.2 Chimeric Antigen Receptor Cell Therapy Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Global Chimeric Antigen Receptor Cell Therapy Market Competition, by Players
3.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.2.2 Top 10 Chimeric Antigen Receptor Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions
4.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Regions
4.2 North America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
5.1 North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
5.2 USA Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries
6.1 Europe Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries
7.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
7.2 China Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries
8.1 South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chimeric Antigen Receptor Cell Therapy by Countries
9.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Type
10.1 Global Chimeric Antigen Receptor Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Type (2020-2026)
10.3 Monotherapy Revenue Growth Rate (2015-2026)
10.4 Combination Therapy Revenue Growth Rate (2015-2026)
11 Global Chimeric Antigen Receptor Cell Therapy Market Segment by Application
11.1 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 Chimeric Antigen Receptor Cell Therapy Market Forecast by Application (2020-2026)
11.3 Acute Leukemia Revenue Growth (2014-2019)
11.4 Non-hodgkin's Lymphoma Revenue Growth (2014-2019)
11.5 Multiple Myeloma Revenue Growth (2014-2019)
11.6 Transplant Rejection Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2020-2026)
12.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2020-2026)
12.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Regions (2020-2026)
12.3 North America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2026)
12.4 Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2026)
12.5 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2026)
12.6 South America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2026)
12.7 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2020-2026)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Chimeric Antigen Receptor Cell Therapy Picture
Table Product Specifications of Chimeric Antigen Receptor Cell Therapy
Table Global Chimeric Antigen Receptor Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Types in 2018
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Application (2015-2026)
Figure Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Applications in 2018
Figure Acute Leukemia Picture
Figure Non-hodgkin's Lymphoma Picture
Figure Multiple Myeloma Picture
Figure Transplant Rejection Picture
Figure Other Picture
Table Global Market Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2026
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (2015-2026)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Autolus Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Bellicum Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table CARsgen Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celgene Corp Basic Information, Manufacturing Base and Competitors
Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Cellular Biomedicine Group Inc Basic Information, Manufacturing Base and Competitors
Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celularity Inc Basic Information, Manufacturing Base and Competitors
Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celyad SA Basic Information, Manufacturing Base and Competitors
Table Celyad SA Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Fosun Pharmaceutical AG Basic Information, Manufacturing Base and Competitors
Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Hangzhou Converd Co Ltd Basic Information, Manufacturing Base and Competitors
Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Manufacturing Base and Competitors
Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table HRAIN Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Kite Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Nanjing Legend Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table NantKwest Inc Basic Information, Manufacturing Base and Competitors
Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Nkarta Inc Basic Information, Manufacturing Base and Competitors
Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Sorrento Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Type and Applications
Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players in 2017
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Chimeric Antigen Receptor Cell Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Chimeric Antigen Receptor Cell Therapy Revenue Market Share in 2018
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Regions in 2018
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table North America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
Table North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure USA Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Europe Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Germany Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UK Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure France Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure China Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure India Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table South America Chimeric Antigen Receptor Cell Therapy Revenue by Countries (2014-2019)
Table South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Brazil Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Chimeric Antigen Receptor Cell Therapy Revenue and Growth Rate (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Type (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Type (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Type in 2018
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Forecast by Type (2019-2024)
Figure Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Type (2019-2024)
Figure Global Monotherapy Revenue Growth Rate (2014-2019)
Figure Global Combination Therapy Revenue Growth Rate (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue by Application (2014-2019)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application in 2018
Table Global Chimeric Antigen Receptor Cell Therapy Revenue Forecast by Application (2019-2024)
Figure Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Application (2019-2024)
Figure Global Acute Leukemia Revenue Growth Rate (2014-2019)
Figure Global Non-hodgkin's Lymphoma Revenue Growth Rate (2014-2019)
Figure Global Multiple Myeloma Revenue Growth Rate (2014-2019)
Figure Global Transplant Rejection Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Chimeric Antigen Receptor Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
Figure Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
Figure South America Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Forecast (2019-2024)

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz